Glaukos Corporation
GKOS
Kedudukan dalam Saham
#2115
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Harga Saham
$164.43
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$9.70B
Perubahan (1 hari)
-0.95%
Perubahan (1 tahun)
88.63%
Negara
US
Perdagangan Glaukos Corporation (GKOS)
Kategori
Healthcare
EPS untuk Glaukos Corporation (GKOS)
EPS setakat June 2026 TTM: $-3.25
Menurut laporan kewangan terkini dan harga saham Glaukos Corporation, EPS semasa syarikat (TTM) adalah $-3.25. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-2.78 peningkatan berbanding EPS tahun 2022 iaitu $-2.09.
Sejarah EPS untuk Glaukos Corporation dari 2012 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-3.25 | 17.33% |
| 2024 | $-2.77 | -0.36% |
| 2023 | $-2.78 | 33.01% |
| 2022 | $-2.09 | 95.33% |
| 2021 | $-1.07 | -60.37% |
| 2020 | $-2.70 | -758.54% |
| 2019 | $0.41 | -210.81% |
| 2018 | $-0.37 | 13,603.70% |
| 2017 | 0.00 | -101.93% |
| 2016 | $0.14 | -106.57% |
| 2015 | $-2.13 | 334.69% |
| 2014 | $-0.49 | -3.92% |
| 2013 | $-0.51 | -94.76% |
| 2012 | $-9.73 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $3.11 | -195.69% |
US
|
|
| $3.59 | -210.46% |
IE
|
|
| $9.73 | -399.38% |
US
|
|
| $2.48 | -176.31% |
US
|
|
| - | - |
DE
|
